PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
June 3, 2026Eskisehir Medical Journal Eskisehir City Hospital0 citations

A Rare Coexistence of Seropositive Rheumatoid Arthritis and Hla-B27 Positive Crohn-Related Spondyloarthritis

View Full Paper
YTYasemin TombakEEEmel EkşioğluABAjda Bal

Key Points

  • This case highlights the rare coexistence of seropositive rheumatoid arthritis and HLA-B27 positive axial spondyloarthritis, focusing on the importance of monitoring bowel symptoms.
  • Case report of a 64-year-old male with seropositive RA and axial SpA who experienced diarrhea.
  • Histopathological examination and colonoscopy were performed to assess gastrointestinal involvement.
  • Treatment with subcutaneous anti-TNF alpha therapy was administered.
  • The patient had signs of inflammatory bowel disease, confirmed by colonoscopy and histopathological findings.
  • After treatment with anti-TNF alpha therapy, the patient showed significant improvement in symptoms.
  • Emphasizes the need for monitoring skeletal involvement in Crohn's disease prior to bowel-related complaints.

Abstract

Rheumatoid arthritis (RA) is a symmetrical joint inflammation, whereas Crohn's disease (CD) is characterized by granulomatous inflammation. Combining seropositive RA with axial spondyloarthritis (SpA) and human leukocyte antigen (HLA)-B27 positive CD is a rare occurrence. We report the case of a 64-year-old male patient with RA and axial SpA experienced diarrhea recently. He had previously experienced joint pain, swelling, and inflammatory type neck, back, and bilateral hip pain. The patient had discontinued treatment and failed to attend follow-up appointments. He had swollen joints, abdominal distension, tenderness, and inflammatory bowel disease. Colonoscopy revealed numerous linear ulcers in the terminal ileum and aphthous ulcers in the ileocecal valve and sigmoid colon. Histopathological examination indicated active ileitis signs consistent with CD. The patient responded well to subcutaneous anti-tumor necrosis factor (TNF) alpha therapy. This case emphasizes that skeletal involvement in CD can develop before bowel complaints, and patients with axial SpA experiencing bowel symptoms should be closely monitored for potential signs of inflammatory bowel disease.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Tombak et al. (2026) studied this question.

synapsesocial.com/papers/6a1fc530dee9eb8c0dce6941https://doi.org/10.48176/esmj.2026.260
Ask AI
Helpful
Bookmark
Share
View Full Paper